CHICAGO (Reuters) – Genome pioneer J. Craig Venter is teaming up with a unit of United Therapeutics Corp to develop pig lungs that have been genetically altered to be compatible with humans, a feat that, if successful, could address the urgent need for transplant organs for people with end-stage lung disease.